div class=ts-pagebuttonPage 1button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page1jpg target=_blank amp-img class=ts-thumb alt=Page 1: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 2button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page2jpg target=_blank amp-img class=ts-thumb alt=Page 2: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 3button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page3jpg target=_blank amp-img class=ts-thumb alt=Page 3: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 4button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page4jpg target=_blank amp-img class=ts-thumb alt=Page 4: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails4jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 5button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page5jpg target=_blank amp-img class=ts-thumb alt=Page 5: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails5jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 6button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page6jpg target=_blank amp-img class=ts-thumb alt=Page 6: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails6jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 7button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page7jpg target=_blank amp-img class=ts-thumb alt=Page 7: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails7jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 8button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page8jpg target=_blank amp-img class=ts-thumb alt=Page 8: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails8jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 9button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page9jpg target=_blank amp-img class=ts-thumb alt=Page 9: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails9jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 10button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page10jpg target=_blank amp-img class=ts-thumb alt=Page 10: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails10jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 11button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page11jpg target=_blank amp-img class=ts-thumb alt=Page 11: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails11jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 12button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page12jpg target=_blank amp-img class=ts-thumb alt=Page 12: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails12jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 13button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page13jpg target=_blank amp-img class=ts-thumb alt=Page 13: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails13jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 14button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page14jpg target=_blank amp-img class=ts-thumb alt=Page 14: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails14jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 15button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page15jpg target=_blank amp-img class=ts-thumb alt=Page 15: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails15jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 16button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page16jpg target=_blank amp-img class=ts-thumb alt=Page 16: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails16jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 17button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page17jpg target=_blank amp-img class=ts-thumb alt=Page 17: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails17jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 18button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page18jpg target=_blank amp-img class=ts-thumb alt=Page 18: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails18jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 19button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page19jpg target=_blank amp-img class=ts-thumb alt=Page 19: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails19jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 20button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page20jpg target=_blank amp-img class=ts-thumb alt=Page 20: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails20jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 21button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page21jpg target=_blank amp-img class=ts-thumb alt=Page 21: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails21jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 22button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page22jpg target=_blank amp-img class=ts-thumb alt=Page 22: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails22jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 23button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page23jpg target=_blank amp-img class=ts-thumb alt=Page 23: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails23jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 24button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page24jpg target=_blank amp-img class=ts-thumb alt=Page 24: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails24jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 25button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page25jpg target=_blank amp-img class=ts-thumb alt=Page 25: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails25jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 26button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page26jpg target=_blank amp-img class=ts-thumb alt=Page 26: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails26jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 27button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page27jpg target=_blank amp-img class=ts-thumb alt=Page 27: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails27jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 28button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page28jpg target=_blank amp-img class=ts-thumb alt=Page 28: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails28jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 29button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page29jpg target=_blank amp-img class=ts-thumb alt=Page 29: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails29jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 30button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page30jpg target=_blank amp-img class=ts-thumb alt=Page 30: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails30jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 31button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page31jpg target=_blank amp-img class=ts-thumb alt=Page 31: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails31jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 32button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page32jpg target=_blank amp-img class=ts-thumb alt=Page 32: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails32jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 33button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page33jpg target=_blank amp-img class=ts-thumb alt=Page 33: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails33jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 34button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page34jpg target=_blank amp-img class=ts-thumb alt=Page 34: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails34jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 35button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page35jpg target=_blank amp-img class=ts-thumb alt=Page 35: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails35jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 36button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page36jpg target=_blank amp-img class=ts-thumb alt=Page 36: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails36jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 37button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page37jpg target=_blank amp-img class=ts-thumb alt=Page 37: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails37jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 38button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page38jpg target=_blank amp-img class=ts-thumb alt=Page 38: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails38jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 39button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page39jpg target=_blank amp-img class=ts-thumb alt=Page 39: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails39jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 40button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page40jpg target=_blank amp-img class=ts-thumb alt=Page 40: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails40jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 41button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page41jpg target=_blank amp-img class=ts-thumb alt=Page 41: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails41jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 42button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page42jpg target=_blank amp-img class=ts-thumb alt=Page 42: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails42jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 43button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page43jpg target=_blank amp-img class=ts-thumb alt=Page 43: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails43jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 44button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page44jpg target=_blank amp-img class=ts-thumb alt=Page 44: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails44jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 45button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page45jpg target=_blank amp-img class=ts-thumb alt=Page 45: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails45jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 46button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page46jpg target=_blank amp-img class=ts-thumb alt=Page 46: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails46jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 47button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page47jpg target=_blank amp-img class=ts-thumb alt=Page 47: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails47jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 48button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page48jpg target=_blank amp-img class=ts-thumb alt=Page 48: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails48jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 49button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page49jpg target=_blank amp-img class=ts-thumb alt=Page 49: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails49jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 50button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page50jpg target=_blank amp-img class=ts-thumb alt=Page 50: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails50jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 51button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page51jpg target=_blank amp-img class=ts-thumb alt=Page 51: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails51jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 52button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page52jpg target=_blank amp-img class=ts-thumb alt=Page 52: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails52jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 53button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page53jpg target=_blank amp-img class=ts-thumb alt=Page 53: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails53jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 54button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page54jpg target=_blank amp-img class=ts-thumb alt=Page 54: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails54jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 55button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page55jpg target=_blank amp-img class=ts-thumb alt=Page 55: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails55jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 56button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page56jpg target=_blank amp-img class=ts-thumb alt=Page 56: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails56jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 57button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page57jpg target=_blank amp-img class=ts-thumb alt=Page 57: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails57jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 58button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page58jpg target=_blank amp-img class=ts-thumb alt=Page 58: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails58jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 59button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page59jpg target=_blank amp-img class=ts-thumb alt=Page 59: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails59jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 60button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page60jpg target=_blank amp-img class=ts-thumb alt=Page 60: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails60jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 61button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page61jpg target=_blank amp-img class=ts-thumb alt=Page 61: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails61jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 62button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page62jpg target=_blank amp-img class=ts-thumb alt=Page 62: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails62jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 63button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page63jpg target=_blank amp-img class=ts-thumb alt=Page 63: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails63jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 64button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page64jpg target=_blank amp-img class=ts-thumb alt=Page 64: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails64jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 65button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page65jpg target=_blank amp-img class=ts-thumb alt=Page 65: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails65jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 66button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page66jpg target=_blank amp-img class=ts-thumb alt=Page 66: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails66jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 67button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page67jpg target=_blank amp-img class=ts-thumb alt=Page 67: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails67jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 68button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page68jpg target=_blank amp-img class=ts-thumb alt=Page 68: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails68jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 69button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page69jpg target=_blank amp-img class=ts-thumb alt=Page 69: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails69jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 70button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page70jpg target=_blank amp-img class=ts-thumb alt=Page 70: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails70jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 71button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page71jpg target=_blank amp-img class=ts-thumb alt=Page 71: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails71jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 72button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page72jpg target=_blank amp-img class=ts-thumb alt=Page 72: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails72jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 73button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page73jpg target=_blank amp-img class=ts-thumb alt=Page 73: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails73jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 74button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page74jpg target=_blank amp-img class=ts-thumb alt=Page 74: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails74jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 75button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page75jpg target=_blank amp-img class=ts-thumb alt=Page 75: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails75jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 76button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page76jpg target=_blank amp-img class=ts-thumb alt=Page 76: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails76jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 77button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page77jpg target=_blank amp-img class=ts-thumb alt=Page 77: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails77jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 78button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page78jpg target=_blank amp-img class=ts-thumb alt=Page 78: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails78jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 79button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page79jpg target=_blank amp-img class=ts-thumb alt=Page 79: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails79jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 80button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page80jpg target=_blank amp-img class=ts-thumb alt=Page 80: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails80jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 81button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page81jpg target=_blank amp-img class=ts-thumb alt=Page 81: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails81jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 82button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page82jpg target=_blank amp-img class=ts-thumb alt=Page 82: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails82jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 83button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page83jpg target=_blank amp-img class=ts-thumb alt=Page 83: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails83jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 84button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page84jpg target=_blank amp-img class=ts-thumb alt=Page 84: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails84jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 85button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page85jpg target=_blank amp-img class=ts-thumb alt=Page 85: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails85jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 86button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page86jpg target=_blank amp-img class=ts-thumb alt=Page 86: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails86jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 87button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page87jpg target=_blank amp-img class=ts-thumb alt=Page 87: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails87jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 88button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page88jpg target=_blank amp-img class=ts-thumb alt=Page 88: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails88jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 89button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page89jpg target=_blank amp-img class=ts-thumb alt=Page 89: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails89jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 90button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page90jpg target=_blank amp-img class=ts-thumb alt=Page 90: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails90jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 91button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page91jpg target=_blank amp-img class=ts-thumb alt=Page 91: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails91jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 92button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page92jpg target=_blank amp-img class=ts-thumb alt=Page 92: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails92jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 93button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page93jpg target=_blank amp-img class=ts-thumb alt=Page 93: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails93jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 94button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page94jpg target=_blank amp-img class=ts-thumb alt=Page 94: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails94jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 95button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page95jpg target=_blank amp-img class=ts-thumb alt=Page 95: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails95jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 96button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page96jpg target=_blank amp-img class=ts-thumb alt=Page 96: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails96jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 97button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page97jpg target=_blank amp-img class=ts-thumb alt=Page 97: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails97jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 98button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page98jpg target=_blank amp-img class=ts-thumb alt=Page 98: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails98jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 99button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page99jpg target=_blank amp-img class=ts-thumb alt=Page 99: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails99jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 100button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page100jpg target=_blank amp-img class=ts-thumb alt=Page 100: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails100jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 101button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page101jpg target=_blank amp-img class=ts-thumb alt=Page 101: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails101jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 102button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page102jpg target=_blank amp-img class=ts-thumb alt=Page 102: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails102jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 103button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page103jpg target=_blank amp-img class=ts-thumb alt=Page 103: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails103jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 104button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page104jpg target=_blank amp-img class=ts-thumb alt=Page 104: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails104jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 105button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page105jpg target=_blank amp-img class=ts-thumb alt=Page 105: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails105jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 106button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page106jpg target=_blank amp-img class=ts-thumb alt=Page 106: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails106jpg width=142 height=106 layout=responsive amp-imga divpBACKUP SLIDESpdivdiv class=ts-pagebuttonPage 107button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page107jpg target=_blank amp-img class=ts-thumb alt=Page 107: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails107jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 108button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page108jpg target=_blank amp-img class=ts-thumb alt=Page 108: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails108jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 109button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page109jpg target=_blank amp-img class=ts-thumb alt=Page 109: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails109jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 110button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page110jpg target=_blank amp-img class=ts-thumb alt=Page 110: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails110jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 111button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page111jpg target=_blank amp-img class=ts-thumb alt=Page 111: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails111jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 112button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page112jpg target=_blank amp-img class=ts-thumb alt=Page 112: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails112jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 113button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page113jpg target=_blank amp-img class=ts-thumb alt=Page 113: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails113jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 114button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page114jpg target=_blank amp-img class=ts-thumb alt=Page 114: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails114jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 115button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page115jpg target=_blank amp-img class=ts-thumb alt=Page 115: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails115jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 116button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page116jpg target=_blank amp-img class=ts-thumb alt=Page 116: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails116jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=ts-pagebuttonPage 117button div class=ts-image a href=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5page117jpg target=_blank amp-img class=ts-thumb alt=Page 117: PowerPoint Presentation · co-5 ALIS Fulfills Criteria for Accelerated Approval Criteria A Serious condition B Meaningful advantage over available therapy C Demonstrated src=https:reader042vdocumentsnetreader042viewer20220315065c90dac109d3f214598cdd0ehtml5thumbnails117jpg width=142 height=106 layout=responsive amp-imga divdiv